IVD契約製造市場規模：佔有率、成長分析、按產品類型、按技術、按服務類型、按地區 - 產業預測，2024-2031年

2022年，IVD契約製造的全球市場規模為148億美元，從2023年的165.2億美元成長到2031年的397.4億美元，在預測期（2024-2031年）年複合成長率為11.60%。

體外診斷藥物（IVD）契約製造市場預計將顯著成長，這主要是由於對個人化醫療（包括基因表現、生物標記發現和標靶治療）日益關注的推動。隨著醫療保健成本持續上升，尤其是在新興市場，對標準化診斷解決方案的需求不斷增加，推動了這一趨勢。這項市場擴張的主要驅動力包括數位病理學、次世代定序和創新影像技術等診斷技術的進步，這些技術有助於開發更準確的診斷產品。 IVD 涵蓋廣泛的應用，從個人化妊娠測試到用於糖尿病管理的血糖值監測，增加了其市場吸引力。此外，製藥業越來越依賴體外診斷藥物，這些藥物在最終用戶中越來越受歡迎。人們對有助於及時檢測、診斷和疾病預防的照護端監測設備也越來越感興趣。隨著高速診斷設備的客製化變得更加普遍，這種趨勢預計將持續下去。此外，許多市場相關人員積極參與實施促進該產業成長的策略，進一步鞏固了細分市場的發展軌跡。隨著情況的發展，符合這些趨勢的相關人員可能會在不斷擴大的市場中抓住重要的商機。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二級資料和一級資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 依細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制因素和挑戰
• 波特分析及影響
  • 競爭公司之間的敵對關係
  • 替代品的威脅
  • 買方議價能力
  • 新進入者的威脅
  • 供應商的議價能力

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 技術進步
• 監管環境
• 專利分析
• 價值鏈分析
• 案例研究分析
• 客戶和購買標準分析
• 市場吸引力指數
• 供應鏈分析
• 價格分析

依產品類型分類的IVD契約製造市場規模

• 市場概況
• 消耗品
• 裝置

IVD契約製造市場規模：依技術分類

• 市場概況
• 免疫檢測
• 臨床化學
• 分子診斷
• 血液學
• 微生物學
• 凝血和止血
• 其他技術

依服務類型分類的IVD契約製造市場規模

• 市場概況
• 製造服務
• 檢測開發
• 其他服務

IVD契約製造市場規模：依地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 西班牙
  • 法國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東、非洲

競爭資訊

• 前5名企業比較
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2023）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 依細分市場分類的佔有率分析
  • 收益與前一年同期比較（2021-2023）

主要企業簡介

• Jabil Inc.
• Sanmina Corporation
• TE Connectivity
• Celestica, Inc.
• West Pharmaceutical Services, Inc.
• Savyon Diagnostics, Ltd.
• KMC Systems
• Cenogenics Corporation
• Nova Biomedical
• Cone Bioproducts
• Kimball Electronics, Inc.
• Roche Diagnostics
• Viant Medical Holdings, Inc.
• Sysmex Corporation
• Stratec SE
• Thermo Fisher Scientific, Inc.
• Fujirebio
• Biokit（Werfen）
• Sekisui
• Prestige Diagnostics

結論和建議

Global IVD Contract Manufacturing Market size was valued at USD 14.80 billion in 2022 and is poised to grow from USD 16.52 billion in 2023 to USD 39.74 billion by 2031, growing at a CAGR of 11.60% during the forecast period (2024-2031).

The in vitro diagnostics (IVD) contract manufacturing market is poised for significant growth, largely fueled by the rising focus on personalized medicine, which encompasses gene expression, biomarker discovery, and targeted therapies. This trend is bolstered by the increasing demand for standardized diagnostic solutions as healthcare costs continue to escalate, particularly in emerging markets. Key drivers of this market expansion include advancements in diagnostic technologies such as digital pathology, next-generation sequencing, and innovative imaging techniques, which aid in the development of more accurate diagnostic products. IVDs encompass a diverse array of applications, from personalized pregnancy tests to blood glucose monitoring for diabetes management, thereby broadening their market appeal. Furthermore, the pharmaceutical industry's growing reliance on IVD devices amplifies their adoption among end users. There is also a notable surge in interest surrounding point-of-care monitoring devices, which facilitate timely testing, diagnosis, and disease prevention. This trend is expected to progress as customization in high-speed diagnostic devices becomes more prevalent. Additionally, numerous market players are actively engaged in executing strategies that enhance growth in this segment, further solidifying the IVD contract manufacturing market's trajectory. As the landscape evolves, stakeholders who align with these trends are likely to capture significant opportunities within the expanding market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Ivd Contract Manufacturing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Ivd Contract Manufacturing Market Segmental Analysis

Global IVD Contract Manufacturing Market is segmented into Product Type, Technology, Service Type, and region. By Product Type, the market is classified into Consumables, and Equipment. Depending on the Technology, it is categorized into Immunoassays, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, and Other Technologies. According to Service Type, the market is divided into Manufacturing Services, Assay Development, and Other Services. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Ivd Contract Manufacturing Market

The global IVD contract manufacturing market is primarily driven by the rising demand for advanced In Vitro Diagnostics (IVD) devices, fueled by the increasing prevalence of chronic illnesses, including diabetes, cancer, and heart disease. This escalating need has prompted manufacturers to enhance their productivity to tackle pressing global health challenges effectively. Additionally, contract manufacturers are pivotal in delivering cost-efficient and high-quality solutions, empowering IVD companies to comply with stringent regulatory requirements. As a result, the contract manufacturing sector is positioned to play an essential role in the healthcare ecosystem, supporting innovation and access to critical diagnostic tools worldwide.

Restraints in the Global Ivd Contract Manufacturing Market

The Global IVD Contract Manufacturing market encounters significant constraints primarily due to elevated development and manufacturing costs. Producing IVD devices demands substantial financial commitments for research, regulatory compliance, and state-of-the-art manufacturing facilities. These high expenses associated with creating innovative diagnostic technologies often deter small to medium-sized enterprises from entering the industry, thereby hindering overall market growth. The financial burden can limit the capacity of these companies to invest in necessary advancements and expertise, which could otherwise enhance their competitiveness and ability to innovate within the IVD landscape. Consequently, the market's expansion is restricted by these financial barriers.

Market Trends of the Global Ivd Contract Manufacturing Market

The Global IVD Contract Manufacturing market is increasingly witnessing a trend towards outsourcing production to emerging markets, notably in the Asia-Pacific region. This shift is driven by the allure of reduced labor costs, the availability of a skilled workforce, and the imperative to manage rising manufacturing pressures. Companies are capitalizing on these advantages to enhance operational efficiency while accessing new growth opportunities in expanding markets. This trend not only allows manufacturers to significantly lower expenses but also positions them to cater to the increasing demand for in vitro diagnostics in these dynamic regions, ultimately reshaping the industry's competitive landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Value Chain Analysis
• Case Study Analysis
• Customer & Buying Criteria Analysis
• Market Attractiveness Index
• Supply Chain Analysis
• Pricing Analysis

Global IVD Contract Manufacturing Market Size by Product Type & CAGR (2024-2031)

• Market Overview
• Consumables
• Equipment

Global IVD Contract Manufacturing Market Size by Technology & CAGR (2024-2031)

• Market Overview
• Immunoassays
• Clinical Chemistry
• Molecular Diagnostics
• Hematology
• Microbiology
• Coagulation & Hemostasis
• Other Technologies

Global IVD Contract Manufacturing Market Size by Service Type & CAGR (2024-2031)

• Market Overview
• Manufacturing Services
• Assay Development
• Other Services

Global IVD Contract Manufacturing Market Size & CAGR (2024-2031)

• North America, (Product Type, Technology, Service Type)
  • US
  • Canada
• Europe, (Product Type, Technology, Service Type)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Product Type, Technology, Service Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Product Type, Technology, Service Type)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (Product Type, Technology, Service Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Jabil Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanmina Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TE Connectivity
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Celestica, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• West Pharmaceutical Services, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Savyon Diagnostics, Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KMC Systems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cenogenics Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nova Biomedical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cone Bioproducts
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kimball Electronics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Viant Medical Holdings, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stratec SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujirebio
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biokit (Werfen)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sekisui
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Prestige Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation